Marketscreener, stock market website
2ced4c84892f2.TKruFPoKOSss3iLoXEa7814tdxEM7XIxZ-CkSrC29QQ.Gu6_Z4pBDmodtRufDwDLoDAfBiNgrEccIqLJLdP8oj0Bh6dOqkN3Y1-Xaw
Logo MarketScreener
Back
Logo MarketScreener

Enter your password

Forgot your password ?
Subscribe
  • Markets
    Stocks
    Top Capitalization
    India
    North America
    Europe
    Asia
    Middle East
    Sector Research
    Company Calendar
    Equity Analysis
    Most popular
    BBVA
    OPTINOSEPAR
    BSE LIMITED
    HSBC HOLDINGS PLC
    EUROPEN ENDUSTRI INSAAT SANAYI VE TICARET
    TAB GIDA SANAYI VE TICARET
    ICG PLC
    Indices
    Homepage
    Rankings
    Europe
    America
    Asia
    Africa
    Index Analysis
    Indices News
    NIFTY 50
    NIFTY 500
    BSE SENSEX 30
    S&P 500
    DOW JONES
    NASDAQ 100
    HANG SENG
    TOPIX
    Currency / Forex
    Homepage
    Rankings
    Currency Cross Rate
    Currency Converter
    Forex Analysis
    Currencies News
    INR / USD
    INR / CNY
    INR / HKD
    INR / IDR
    INR / KRW
    Commodities
    Homepage
    Energy
    Precious metals
    Agriculture
    Industrial Metals
    Livestock and Cattle
    GOLD
    CRUDE OIL (WTI)
    CRUDE OIL (BRENT)
    SILVER
    PLATINUM
    Cryptocurrencies
    Homepage
    Rankings
    Charts
    Analysis
    News
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
    Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
    Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
    Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    Interest Rates
    Homepage
    Yield Curve
    Developed Markets
    Emerging Markets
    ETF
    Summary
    Screener
    Analysis
    News
  • News
    All News
    Macroeconomics
    Policy
    Geopolitics
    Technology
    International Trade
    Military conflicts
    Taxation
    Sustainable development
    Legal, Regulation and Crime
    Companies
    Financial Results
    Analyst Recommendations
    Transcripts
    Press releases
    Insider transaction
    Controversies
    Innovations and expansions
    IPOs
    Rumors
    Activism
    Negative surprises
    Positive surprises
    New Contracts
    Indices
    Currency / Forex
    Commodities
    Cryptocurrencies
    ETF
    Interest Rates
    Funds
    Economy
    Sectors
    All our articles
    Most Read News
    Key News
    Business Insiders
  • Analysis
    All Articles
    Must Read
    Interviews
    Stocks
    Indices
    Currencies
    Commodities
    ETF
    Cryptocurrencies
    Interest Rates
  • Calendar
    Economic Calendar
    Company Calendar
    Dividend calendar
  • Stock Picks
    All our investments
    Asia, Pacific
    Europe
    United States
  • Portfolios
    Asian Portfolio
    European Portfolio
    USA Portfolio
    Virtual Portfolios
  • Watchlists
    My Watchlists
    Watchlists
    My previous session
    My most visited
    Most popular
    Investment Style
    Homepage
    Quality stocks
    Growth stocks at reasonable prices
    Low capital intensity
    Monthly dividends
    Yield stocks
    Dividend Aristocrats
    Investment Themes
    Homepage
    Cloud Computing
    The SPAC
    Semiconductors
    Ageing Population
    REITS
    Wind energy
  • Trading
    Market Timing
    Key News
    Pre/Post-Market Movers
    Technical Alerts
  • Screeners
    Stocks
    ETF
    Insider transactions
  • Tools
    Dynamic Chart
    Currency Converter
  • Rankings
    Top Movers
    Short-Term Gainers & Losers
    Long-term Gainers & Losers
    Unusual Volumes
    New Historical Highs
    New Historical Lows
    Pre/Post-Market Movers
    Top Fundamentals
    Fundamental Composite
    Sales Growth
    Earnings Growth
    Profitability
    Finances
    Visibility Rankings
    Rankings Valuation
    Valuation Composite
    Market Cap
    P/E
    Enterprise Value
    Yield
    Price to Book (PBR)
    Free Cash Flow (FCF)
    Top Consensus
    Consensus Composite
    Analyst Opinion
    Target Price
    Opinion Divergences
    Estimates Revisions
    Analyst Coverage
    Technical Analysis Rankings
    RSI
    GAPS
    STIM
    Daily Breakouts
    Weekly Breakouts
    Trends
    Volatility
    Top ranking ESG
    ESG MSCI
    Environment
    Social
    Governance
    Islamic Finance
    Paris Agreement
Indian Edition
Subscribe
  • Homepage
  • Markets
    • Stocks
      • Top Capitalization
      • India
      • North America
      • Europe
      • Asia
      • Middle East
      • Sector Research
      • Company Calendar
      • Equity Analysis
      • Most popular
      • BBVA
      • OPTINOSEPAR
      • BSE LIMITED
      • HSBC HOLDINGS PLC
      • EUROPEN ENDUSTRI INSAAT SANAYI VE TICARET
      • TAB GIDA SANAYI VE TICARET
      • ICG PLC
    • Indices
      • Homepage
      • Rankings
      • Europe
      • America
      • Asia
      • Africa
      • Index Analysis
      • Indices News
      • NIFTY 50
      • NIFTY 500
      • BSE SENSEX 30
      • S&P 500
      • DOW JONES
      • NASDAQ 100
      • HANG SENG
      • TOPIX
    • Currency / Forex
      • Homepage
      • Rankings
      • Currency Cross Rate
      • Currency Converter
      • Forex Analysis
      • Currencies News
      • INR / USD
      • INR / CNY
      • INR / HKD
      • INR / IDR
      • INR / KRW
    • Commodities
      • Homepage
      • Energy
      • Precious metals
      • Agriculture
      • Industrial Metals
      • Livestock and Cattle
      • GOLD
      • CRUDE OIL (WTI)
      • CRUDE OIL (BRENT)
      • SILVER
      • PLATINUM
    • Cryptocurrencies
      • Homepage
      • Rankings
      • Charts
      • Analysis
      • News
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BITCOINBITCOIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>ETHEREUMETHEREUM
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>BINANCE COINBINANCE COIN
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>SOLANASOLANA
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CARDANOCARDANO
      • Logo Crypto <span class='ml-5 txt-link txt-s1'>CHAINLINKCHAINLINK
    • Interest Rates
      • Homepage
      • Yield Curve
      • Developed Markets
      • Emerging Markets
    • ETF
      • Summary
      • Screener
      • Analysis
      • News
  • News
    • All News
      • Macroeconomics
      • Policy
      • Geopolitics
      • Technology
      • International Trade
      • Military conflicts
      • Taxation
      • Sustainable development
      • Legal, Regulation and Crime
    • Companies
      • Financial Results
      • Analyst Recommendations
      • Transcripts
      • Press releases
      • Insider transaction
      • Controversies
      • Innovations and expansions
      • IPOs
      • Rumors
      • Activism
      • Negative surprises
      • Positive surprises
      • New Contracts
    • Indices
    • Currency / Forex
    • Commodities
    • Cryptocurrencies
    • ETF
    • Interest Rates
    • Funds
    • Economy
    • Sectors
    • All our articles
    • Most Read News
    • Key News
    • Business Insiders
  • Analysis
    • All Articles
    • Must Read
    • Interviews
    • Stocks
    • Indices
    • Currencies
    • Commodities
    • ETF
    • Cryptocurrencies
    • Interest Rates
  • Calendar
    • Economic Calendar
    • Company Calendar
    • Dividend calendar
  • Stock Picks
    • All our investments
    • Asia, Pacific
    • Europe
    • United States
  • Portfolios
    • Asian Portfolio
    • European Portfolio
    • USA Portfolio
    • Virtual Portfolios
  • Watchlists
    • My Watchlists
      • Watchlists
      • My previous session
      • My most visited
      • Most popular
    • Investment Style
      • Homepage
      • Quality stocks
      • Growth stocks at reasonable prices
      • Low capital intensity
      • Monthly dividends
      • Yield stocks
      • Dividend Aristocrats
    • Investment Themes
      • Homepage
      • Cloud Computing
      • The SPAC
      • Semiconductors
      • Ageing Population
      • REITS
      • Wind energy
  • Trading
    • Market Timing
    • Key News
    • Pre/Post-Market Movers
    • Technical Alerts
  • Screeners
    • Stocks
    • ETF
    • Insider transactions
  • Tools
    • Dynamic Chart
    • Currency Converter
  • Rankings
    • Top Movers
      • Short-Term Gainers & Losers
      • Long-term Gainers & Losers
      • Unusual Volumes
      • New Historical Highs
      • New Historical Lows
    • Pre/Post-Market Movers
    • Top Fundamentals
      • Fundamental Composite
      • Sales Growth
      • Earnings Growth
      • Profitability
      • Finances
      • Visibility Rankings
    • Rankings Valuation
      • Valuation Composite
      • Market Cap
      • P/E
      • Enterprise Value
      • Yield
      • Price to Book (PBR)
      • Free Cash Flow (FCF)
    • Top Consensus
      • Consensus Composite
      • Analyst Opinion
      • Target Price
      • Opinion Divergences
      • Estimates Revisions
      • Analyst Coverage
    • Technical Analysis Rankings
      • RSI
      • GAPS
      • STIM
      • Daily Breakouts
      • Weekly Breakouts
      • Trends
      • Volatility
    • Top ranking ESG
      • ESG MSCI
      • Environment
      • Social
      • Governance
      • Islamic Finance
      • Paris Agreement
Switch edition
Stock INO INOVIO PHARMACEUTICALS, INC.
Add to a list

Inovio Pharmaceuticals, Inc.

Stocks

INO

US45773H4092

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
01:30:00 06/08/2026 am IST
5-day change 1st Jan Change
0.6770 USD +2.10% Intraday chart for Inovio Pharmaceuticals, Inc. -34.90% -61.09%
30/07 Top Premarket Decliners MT
03/07 Inovio Pharmaceuticals Files $300 Million Mixed Shelf Offering MT
Summary
Quotes
Charts
Technical Analysis Static Chart News Chart Sector Chart Comparison Chart Relative Strength Chart
News
All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies
Company
Profile Governance Share ownership Insider transactions Connections
Financials
Analysts' Forecasts Income Statement Balance Sheet Cash flow Financial Ratios Business Segments
Valuation
Consensus
Analysts' Opinion Estimates Revisions
Ratings
Calendar
Sector
Sector performance Sector valuations Sector dividends Financial comparisons Sector ratings Sector consensus Sector revisions
ETFs
All News Broker Recommendations Highlights Insiders Transcripts Press Releases Official Publications Other languages MarketScreener Editorial Features MarketScreener Strategies

Top Premarket Decliners

Published on 07/30/2026 at 06:14 pm IST

MT Newswires
This article is reserved for our members.
Log in to continue
Continue with Google Continue with Apple Continue with LinkedIn
or by email
Continue with an email.
Create an account with Google Create an account with Apple Create an account with LinkedIn
or by email
Create an account
For unlimited access, Check out our subscriptions.

Latest news about Inovio Pharmaceuticals, Inc.

30/07 Top Premarket Decliners MT
03/07 Inovio Pharmaceuticals Files $300 Million Mixed Shelf Offering MT
02/07 Certain Restricted Stock Units of Inovio Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 2-JUL-2026. CI
02/07 Certain Stock Options of Inovio Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 2-JUL-2026. CI
02/07 Certain Common Stock of Inovio Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 2-JUL-2026. CI
29/06 Inovio Pharmaceuticals, Inc.(NasdaqCM:INO) added to Russell 3000E Growth Benchmark CI
29/06 Inovio Pharmaceuticals, Inc.(NasdaqCM:INO) added to Russell Microcap Growth Benchmark Index CI
04/06 Inovio Pharmaceuticals, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-04-2026 08:45 AM
22/05 Inovio Says China Partner Reported VGX-3100 Phase 3 Trial Met Primary Efficacy Endpoint in Cervical Dysplasia Patients MT
14/05 Inovio reports first quarter 2026 financial results and recent business highlights RE
14/05 Inovio Pharmaceuticals, Inc., Q1 2026 Earnings Call, May 13, 2026
14/05 Inovio Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 CI
02/04 Inovio Pharmaceuticals Prices $17.5 Million Public Offering MT
02/04 Inovio announces pricing of $17.5 million public offering RE
13/03 Inovio Pharmaceuticals, Inc. Reports Earnings Results for the Full Year Ended December 31, 2025 CI

Chart Inovio Pharmaceuticals, Inc.

Chart Inovio Pharmaceuticals, Inc.
INO: Dynamic Chart

Company Profile

Logo Inovio Pharmaceuticals, Inc.
Inovio Pharmaceuticals, Inc. is a biotechnology company focused on developing and commercializing deoxyribonucleic acid (DNA) medicines to help treat and protect people from human papillomavirus (HPV)-related diseases, cancer, and infectious diseases. Its proprietary investigational CELLECTRA devices are designed to deliver the plasmids into the body’s cells for optimal effect, without the use of chemical adjuvants, lipid nanoparticles or viral vectors. Its lead candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease caused by HPV-6 and HPV-11. Its DNA medicines in the pipeline include INO-3112 for the Treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma, VGX-3100 for the Treatment of HPV-related Cervical HSIL, VGX-3100 for the Treatment of Anal or Perianal HSIL, INO-5401 for the Treatment of Glioblastoma Multiforme (GBM), and INO-5401 for the Prevention of Cancer for People with BRCA1/2 Mutation.
Employees
112
Sector
Biotechnology & Medical Research
Calendar
13/08 Earnings release - Q2 2026
More about the company

Income Statement and Estimates

More financial data

Ratings

Trader

Trader

This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

Investor

Investor

This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.

-
Global

Global

This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.

-
Quality

Quality

This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.

-
ESG MSCI

ESG MSCI

The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

BB
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
0.6770USD
Average target price
2.767USD
Spread / Average Target
+308.67%
Consensus
EPS Estimates
Revisions to estimates

Quarterly revenue - Rate of surprise

Company calendar
Indices Europe America Asia

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
My Watchlist
 

My lists
Rankings
 

More Rankings
Rankings
 

More Rankings

Currency / Forex

Commodities

Cryptocurrencies

Interest Rates

  1. Stock Market
  2. Stock Market News
  3. Top Premarket Decliners
Best financial portal

Best financial
portal

More than 20 yearsat your side

More than 20 years
at your side

Trustpilot
13,00,000 +members

13,00,000 +
members

Quick & easycancellation

Quick & easy
cancellation

Our Expertsare here for you

Our Experts
are here for you

Download from Apple Store

OUR EXPERTS ARE HERE FOR YOU

Monday - Friday 9am-6pm CET

Contact us
MarketScreener, Stock Market Live
Legal information | Cookie settings | About us | Copyright © 2026 Surperformance SAS. All rights reserved.
Stock quotes are provided by Factset, Morningstar and S&P Capital IQ
As early as today, start finding the best investment opportunities!

Select your edition

All financial news and data tailored to specific country editions

NORTH AMERICA

MarketScreener
United-States
MarketScreener Canada
Canada

MIDDLE EAST

MarketScreener Saudi Arabia
Saudi Arabia
MarketScreener UAE Emirates
United Arab Emirates

EUROPE

Zonebourse
France
MarketScreener Deutschland
Deutschland
Zonebourse Suisse
Suisse
MarketScreener Schweiz
Schweiz
MarketScreener Italia
Italia
MarketScreener Österreich
Österreich
MarketScreener België
België
MarketScreener Nederland
Nederland
MarketScreener España
España
MarketScreener Sverige
Sverige
MarketScreener UK
United Kingdom

APAC

MarketScreener Australia
Australia
MarketScreener India
India
MarketScreener Hong Kong
Hong Kong